Partial OSK reprogramming rejuvenates engram neurons in aged mice, improving memory by over 50%, with recent studies enhancing safety and biotech firms advancing towards human trials. New research sho...
Recent studies reveal elevated IL-6 levels strongly correlate with Alzheimer’s and mild cognitive impairment, highlighting inflammaging’s role and potential for lifestyle and drug interven...
Analytical post exploring CAR-T cell therapy’s potential to treat Alzheimer’s by targeting amyloid plaques, with insights from recent clinical trials and cost-benefit considerations. Innov...
Recent neuroscience studies reveal that functional amyloids, regulated by chaperone proteins, are essential for long-term memory, challenging traditional views and offering new therapeutic avenues for...
Gut Microbiome Alterations Linked to Early Alzheimer’s Risk, Revealing New Pathways for Intervention
Recent studies connect gut microbiome changes to mild cognitive impairment, highlighting the microbiota-gut-brain axis’s role in early Alzheimer’s detection and potential probiotic-based t...
Emerging research identifies mitochondrial dysfunction as a critical factor in Alzheimer’s disease, with new therapies and lifestyle interventions offering hope for early intervention and improv...
Recent studies reveal that age-related proteasomal decline activates the cGAS-STING pathway through mitochondrial DNA leakage, fueling chronic inflammation linked to Alzheimer’s, with exercise a...
New research reveals APOE ε3 and ε4 variants are implicated in most Alzheimer’s cases, sparking debates on genetic screening, lifestyle changes, and gene therapy in prevention strategies. A gr...
Recent studies reveal that cystathionine γ-lyase (CSE) deficiency accelerates brain aging via reduced hydrogen sulfide, offering new therapeutic avenues for neurodegenerative diseases. Groundbreaking...
This article explores how senotherapeutics target senescent cells in the brain to reduce neuroinflammation and improve cognition, based on recent preclinical studies and emerging clinical trials. Emer...
